GB201720624D0 - Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations - Google Patents

Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations

Info

Publication number
GB201720624D0
GB201720624D0 GBGB1720624.4A GB201720624A GB201720624D0 GB 201720624 D0 GB201720624 D0 GB 201720624D0 GB 201720624 A GB201720624 A GB 201720624A GB 201720624 D0 GB201720624 D0 GB 201720624D0
Authority
GB
United Kingdom
Prior art keywords
cyanobenzoyl
methylbenzamide
pyrazol
cyclopropyl
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1720624.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mereo Biopharma 1 Ltd
Original Assignee
Mereo Biopharma 1 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mereo Biopharma 1 Ltd filed Critical Mereo Biopharma 1 Ltd
Priority to GBGB1720624.4A priority Critical patent/GB201720624D0/en
Publication of GB201720624D0 publication Critical patent/GB201720624D0/en
Priority to EP18819366.8A priority patent/EP3585383B1/en
Priority to ES18819366T priority patent/ES2882978T3/en
Priority to AU2018381874A priority patent/AU2018381874A1/en
Priority to CA3085544A priority patent/CA3085544A1/en
Priority to EP21156673.2A priority patent/EP3845228A1/en
Priority to JP2020531614A priority patent/JP7372680B2/en
Priority to PT188193668T priority patent/PT3585383T/en
Priority to PL18819366T priority patent/PL3585383T3/en
Priority to HUE18819366A priority patent/HUE054266T2/en
Priority to PCT/GB2018/053591 priority patent/WO2019116022A1/en
Priority to US15/733,213 priority patent/US11234967B2/en
Priority to KR1020207019714A priority patent/KR20200097310A/en
Priority to DK18819366.8T priority patent/DK3585383T3/en
Ceased legal-status Critical Current

Links

GBGB1720624.4A 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations Ceased GB201720624D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1720624.4A GB201720624D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations
DK18819366.8T DK3585383T3 (en) 2017-12-11 2018-12-11 USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE
JP2020531614A JP7372680B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease.
PL18819366T PL3585383T3 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
AU2018381874A AU2018381874A1 (en) 2017-12-11 2018-12-11 Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
CA3085544A CA3085544A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
EP21156673.2A EP3845228A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
EP18819366.8A EP3585383B1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PT188193668T PT3585383T (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
ES18819366T ES2882978T3 (en) 2017-12-11 2018-12-11 Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
HUE18819366A HUE054266T2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PCT/GB2018/053591 WO2019116022A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
US15/733,213 US11234967B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
KR1020207019714A KR20200097310A (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbation of chronic obstructive pulmonary disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1720624.4A GB201720624D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations

Publications (1)

Publication Number Publication Date
GB201720624D0 true GB201720624D0 (en) 2018-01-24

Family

ID=61007027

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1720624.4A Ceased GB201720624D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations

Country Status (1)

Country Link
GB (1) GB201720624D0 (en)

Similar Documents

Publication Publication Date Title
HK1253580A1 (en) Use of cannabinoids in the treatment of epilepsy
GB2568809B (en) Use of cannabinoids in the treatment of epilepsy
GB2568471B (en) Use of cannabinoids in the treatment of epilepsy
PT3334422T (en) Use of cannabinoids in the treatment of epilepsy
IL274769A (en) Use of cannabinoids in the treatment of epilepsy
GB201713872D0 (en) Autonomous delivery of items
ZA202006636B (en) Use of sublingual dexmedetomidine for the treatment of agitation
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
HUE048545T2 (en) Duplex stainless steel and use thereof
IL264813B (en) 2-oxo-imidazopyridines and their use
ZA201605222B (en) Pyrazolone compounds and uses thereof
HK1249851A1 (en) Treatment and prevention of the common cold using povidone-iodine
ZA201806511B (en) Glycoalkaloid combinations and various uses thereof
PT3585383T (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
GB201720624D0 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations
PL3585382T3 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
ZA201902263B (en) Helical impeller
AP00792S1 (en) Water purification and dispensing divice
GB201700340D0 (en) fluid manipulation cartridge and controller mechanism
PL3327201T3 (en) Container and use of the same
GB201720622D0 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary
PL3106172T3 (en) Antimicrobial agents and their use
EP3308038C0 (en) Hydraulic valve body and hydraulic valve mechanism comprising the body
GB201707017D0 (en) Narrow boat construction
GB201616087D0 (en) Algae comprising therapeutic and/or nutritional agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)